Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03360916 · ClinicalTrials.gov registry record · Phase 4
Impact of Statin Therapy on Adaptations to Aerobic Exercise
A Phase 4 study of Cardiovascular Diseases, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT03360916 is a Phase 4 study of Cardiovascular Diseases that has completed, run by University of Kansas Medical Center. The registered enrollment target is 52 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03360916, a Phase 4 study of Cardiovascular Diseases, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine how different doses of a statin affect muscle health and exercise.
Conditions Studied
Interventions
- DRUG Placebo
- BEHAVIORAL Exercise Program
- DRUG Lipitor 20Mg Tablet
- DRUG Lipitor 80Mg Tablet
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2024-06-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03360916
The ClinicalTrials.gov registry entry for NCT03360916 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT03360916 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT03360916 about?
NCT03360916 is a clinical study titled "Impact of Statin Therapy on Adaptations to Aerobic Exercise". The purpose of this study is to determine how different doses of a statin affect muscle health and exercise.
What is the current status of trial NCT03360916?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 52 participants. The study started on 2018-02-01. Estimated completion is 2024-06-05.
What conditions does trial NCT03360916 study?
This clinical trial studies the following conditions: Cardiovascular Diseases.
What interventions are being tested in trial NCT03360916?
The interventions under investigation include: Placebo (DRUG), Exercise Program (BEHAVIORAL), Lipitor 20Mg Tablet (DRUG), Lipitor 80Mg Tablet (DRUG).
Who is sponsoring clinical trial NCT03360916?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03360916 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment With Aspirin After Preeclampsia: TAP Trial
RECRUITING · Phase 4
-
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RECRUITING · Phase 4
-
NSAIDs vs. Coxibs in the Presence of Aspirin
RECRUITING · Phase 4
-
Secondhand Tobacco Smoke and Cardiovascular Disease
RECRUITING · Phase 4
-
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
ACTIVE NOT RECRUITING · Phase 4
-
Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.